The invention relates to a pharmacologically active combination and a method of enhancing cognitive performance in a patient suffering from Alzheimers disease comprising administering to said patient a cognitive performance-enhancing amount of melatonin or a melatonin agonist in a combination therapy with a nicotine receptor agonist.